| Literature DB >> 30836938 |
Neema Chami1,2, Rogatus Kabyemera3,4, Tulla Masoza2, Emmanuela Ambrose1,2, Franscisca Kimaro2,5, Neema Kayange1,2, Adolfine Hokororo1,2, Francis F Furia6, Rob Peck1,2.
Abstract
BACKGROUND: It is evident that renal dysfunction (RD) is associated with unique infectious and non-infectious causes in African children. However, little data exists about the prevalence and factors associated with RD in children admitted to African hospitals.Entities:
Keywords: Estimated glomerular filtration rate (e-GFR) and serum creatinine; Renal dysfunction
Mesh:
Year: 2019 PMID: 30836938 PMCID: PMC6402082 DOI: 10.1186/s12882-019-1254-9
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Fig. 1Study enrollment overview
Baseline socio-demographic, clinical and laboratory characteristics of studyparticipants
| Factor | Median/IQR, n (%) | With RD | Without RD | Univariate OR [95% CI] | Multivariate OR [95% CI] | ||
|---|---|---|---|---|---|---|---|
| Female gender | 216 (42.1) | 41 (49.4) | 175 (40.7) | 1.42 [0.89–2.28] | 0.14 | ||
| Age in months | 42 [28–72] | 34 [27–60] | 46.5 [29–72] | 0.99 [0.99–1.00] | 0.10 | ||
| Study site | |||||||
| Bugando Medical Centre | 369 (71.9) | 65 (78.3) | 304 (70.7) | RG0.67 | RG | ||
| Sekou Toure Hospital | 144 (28.1) | 18 (21.7) | 126 (29.3) | [0.38–1.17] | 0.16 | ||
| Water source | |||||||
| Tap water | 350 (68.2) | 58 (69.9) | 292 (67.9) | 0.91 [0.55–1.52] | 0.72 | ||
| Lake or pond water | 163 (31.8) | 25 (30.1) | 138 (32.1) | ||||
| Toilet | |||||||
| Modern flush toilet | 250 (48.7) | 35 (42.2) | 215 (50.0) | 1.37 [0.85–2.21] | 0.19 | ||
| Pit latrine | 263 (51.3) | 48 (57.8) | 215 (50.0) | ||||
| Medical history | |||||||
| Herbal medications use | 187 (36.5) | 45 (54.2) | 142 (33.0) | 2.40 [1.50–3.87] | < 0.001 | 2.11 [1.23–3.61] | 0.007 |
| Gentamycin use | 47 (9.2) | 7 (8.4) | 40 (9.3) | 0.90 [0.34–2.08] | 0.80 | ||
| Ceftriaxone use | 51 (9.9) | 8 (9.6) | 43 (10.0) | 0.96 [0.43–2.12] | 0.92 | ||
| NSAID use | 81 (15.8) | 10 (12.1) | 71 (16.5) | 0.69 [0.34–1.41] | 0.31 | ||
| Throat/skin infection | 36 (7.0) | 11 (13.3) | 25 (5.8) | 2.48 [1.17–5.25] | 0.018 | 2.74 [1.14–6.56] | 0.024 |
| History of SCD | 71 (13.8) | 21 (25.3) | 50 (11.6) | 2.5 [1.44–4.58] | 0.001 | 2.59 [1.31–5.10] | 0.006 |
| Family history of SCD | 40 (7.8) | 6 (7.2) | 34 (7.9) | 0.91 [0.37–2.24] | 0.83 | ||
| Prior surgeries | 28 (5.5) | 1 (1.2) | 27 (6.3) | 0.18 [0.02–1.36] | 0.10 | ||
| Presenting symptoms | |||||||
| Hematuria | 28 (5.5) | 4 (4.8) | 24 (5.6) | 0.86 [0.29–2.54] | 0.78 | ||
| Fever | 373 (72.7) | 59 (71.1) | 314 (73.0) | 0.91 [0.54–1.53] | 0.72 | ||
| Dysuria | 63 (12.3) | 12 (14.5) | 51 (11.9) | 1.26 [0.64–2.48] | 0.51 | ||
| Rash | 28 (5.5) | 6 (7.2) | 22 (5.1) | 1.45 [0.57–3.68] | 0.44 | ||
| Diarrhea | 112 (21.8) | 23 (27.7) | 89 (20.7) | 1.47 [0.86–2.51] | 0.16 | ||
| Bloody diarrhea | 24 (4.7) | 7 (8.4) | 17 (4.0) | 2.24 [0.90–5.58] | 0.08 | ||
| Vomiting | 176 (34.3) | 27 (32.5) | 149 (34.7) | 0.91 [0.55–1.50] | 0.71 | ||
| Recurrent UTI | 45 (8.8) | 5 (6.0) | 40 (9.3) | 0.63 [0.24–1.63] | 0.34 | ||
| Urine output | |||||||
| Normal | 458 (89.3) | 66 (79.5) | 392 (91.2) | RG | RG | ||
| Increased | 15 (2.9) | 2 (2.4) | 13 (3.0) | 0.91 [0.20–4.14] | 0.91 | ||
| Decreased | 40 (7.8) | 15 (18.1) | 25 (5.8) | 3.56 [1.79–7.11] | < 0.001 | 1.11 [0.60–2.06] | 0.73 |
| Presenting signs | |||||||
| Pallor | 212 (41.3) | 32 (38.6) | 180 (41.9) | 0.87 [0.54–1.41] | 0.58 | 0.001 0.62 | |
| Dehydration | 65 (12.7) | 21 (25.3) | 44 (10.2) | 2.97 [1.66–5.33] | < 0.001 | 3.12 [1.56–6.26] | |
| Edema | 59 (11.5) | 15 (18.1) | 44 (10.2) | 1.94 [1.02–3.67] | 0.04 | 1.21 [0.56–2.62] | |
| Vital signs | |||||||
| Pediatric GCS | 15 [15–15] | 15 [15–15] | 15 [15–15] | 0.83 [0.69–0.10] | 0.05 | ||
| Saturation | 97 (95–98) | 97 [94–98] | 97 [95–98] | 0.97 [0.93–1.01] | 0.09 | ||
| Temperature | 37 [36.6–38] | 36.5 [36.2–36.8] | 37 [36.6–38] | 0.92 [0.72–1.16] | 0.47 | ||
| Respiratory rate | 30 [23–40] | 30 [24–40] | 30 [22–38] | 1.01 [0.10–1.03] | 0.08 | ||
| Pulse rate | 112 [98–128] | 110 [98–128] | 112 [98–130] | 0.10 [0.99–1.01] | 0.38 | ||
| Blood pressure | |||||||
| SBP | 90 [85–100] | 90 [85–102] | 90 [85–100] | 1.01 [0.99–1.03] | 0.27 | ||
| DBP | 60 [58–67] | 60 [60–70] | 60 [58–66] | 1.01 [0.99–1.04] | 0.29 | ||
| HIV positivity | 30 (5.8) | 5 (6.0) | 25 (5.8) | 1.04 [0.38–2.79] | 0.94 | ||
| Positive BS for MPS | 59 (11.5) | 16 (19.3) | 43 (10.0) | 2.15 [1.14–4.03] | 0.017 | 2.67 [1.26–5.66] | 0.01 |
| Urine protein | |||||||
| Negative | 417 (81.3) | 46 (55.4) | 371 (86.3) | RG | RG | ||
| Positive | 96 (18.7) | 37 (44.6) | 59 (13.7) | 5.06 [3.03–8.45] | < 0.001 | 5.28 [2.97–9.39] | < 0.001 |
| Urine RBC | |||||||
| Negative | 493 (96.1) | 77 (92.8) | 416 (96.7) | RG | RG | ||
| Positive | 20 (3.9) | 6 (7.2) | 14 (3.3) | 2.32 [0.86–6.21] | 0.10 | ||
| Urine CCA | |||||||
| Negative | 344 (67.1) | 47 (56.6) | 297 (69.1) | RG | RG | ||
| Positive | 169 (32.9) | 36 (43.4) | 133 (30.9) | 1.71 [1.05–2.76] | 0.028 | 1.19 [0.36–3.95] | 0.77 |
| Urine CCA | |||||||
| Negative | 344 (67.1) | 47 (56.6) | 297 (69.1) | RG | RG | ||
| Line faintly visible | 83 (16.2) | 19 (22.9) | 64 (14.9) | 1.88 [1.03–3.41] | 0.039 | 1.31 [0.36–4.80] | 0.68 |
| Line lighter than control | 64 (12.5) | 13 (15.7) | 51 (11.9) | 1.61 [0.81–3.41] | 0.17 | ||
| Intensity equal to control | 22 (4.2) | 4 (4.8) | 18 (4.2) | 1.40 [0.46–4.33] | 0.56 | ||
| Nutritional status | |||||||
| Normal | 268 (52.2) | 47 (56.6) | 221 (51.4) | RG | RG | ||
| Mild malnutrition | 95 (18.5) | 12 (14.5) | 83 (19.3) | 0.68 [0.34–1.34] | 0.23 | ||
| Moderate malnutrition | 76 (14.8) | 12 (14.5) | 64 (14.9) | 0.88 [0.44–1.76] | 0.72 | ||
| Severe malnutrition | 74 (14.5) | 12 (14.5) | 62 (14.4) | 0.91 [0.45–1.82] | 0.79 | ||
CI Confidence interval, RG Reference group, BS for MPS Blood Slide for Malaria Parasites, NSAD Non-Steroidal Anti-inflammatory Drugs, SCD Sickle Cell Disease, UTI Urinary Tract Infection, GCS Glasgow Coma Score, RR Respiratory Rate, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, HIV Human Immunodeficiency Virus, CCA Circulating Cathodic Antigen